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PPAR Promotes Mannose Receptor Gene Expression
in Murine Macrophages and Contributes
to the Induction of This Receptor by IL-13
al., 1982), and immature dendritic cells (Sallusto et al.,
1995). The cell-surface MR mediate binding to a variety
of glycans, notably mannose, fucose, and N-acetylglu-
cosamine, at the surface of pathogenic microorganisms.
MR is sufficient to mediate phagocytosis of Candida
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albicans (Ezekowitz et al., 1990), Pneumocystis cariniiand Bernard Pipy1,*
(Ezekowitz et al., 1991), and Klebsiella pneumoniae1Laboratoire des Macrophages
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and gram-negative bacteria, mycobacteria, and someCellulaires
parasites such as Leishmania donovani (Blackwell et al.,Universite´ Paul Sabatier - EA 2405
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endocytosis of influenza virus (Reading et al., 2000). MRMe´dicale IFR 31
is also implicated in binding with viral proteins. Indeed,Hoˆpital Rangueil
Larkin and coworkers have identified interactions be-2 De´partement de Parasitologie et Mycologie
tween oligosaccharides of the envelope glycoproteinCentre Hospitalier Universitaire
gp120 of HIV-1 and MR (Larkin et al., 1989).Hoˆpital Rangueil
Binding or internalization of natural or synthetic li-1 avenue Jean Poulhe`s
gands of MR may modulate macrophage functions,31403 Toulouse Cedex 4
including respiratory burst and synthesis of proinflam-France
matory cytokines such as IL-1, IL-6, and GM-CSF (Ya-
mamoto et al., 1997) to increase microbicidal capacity.
MR confers an enhanced ability of the order of 200- toSummary
10,000-fold (Tan et al., 1997) to concentrate mannosy-
lated antigens for presentation to T cells by MHC classMacrophage mannose receptor (MMR) is an important
II molecules (MHCII) (Sallusto et al., 1995) and CD1bcomponent of the innate immune system implicated
(Prigozy et al., 1997).in host defense against microbial infections such as
Thus, MR is a key effector molecule in inducing macro-candidiasis and in antigen presentation. We demon-
phage functions and in initiating an early immune re-strate here that the MMR expression is induced in
sponse against invading pathogens. The modulation ofmouse peritoneal macrophages following exposure
this receptor expression in macrophage may be criticalto PPAR ligands or to interleukine-13 (IL-13) via a
in the role of these cells in antigen processing, scaveng-PPAR signaling pathway. Ligand activation of the
ing, and host defense against pathogens.PPAR in macrophages promotes uptake, killing of
Whereas the role of the MR is well known, the mecha-Candida albicans, and reactive oxygen intermediates
nisms involved in regulation of its expression in macro-production triggered by the yeasts through MMR over-
phages are little known. MR expression can be modu-expression. We also show that MMR induction by IL-13
lated both in vivo and in vitro by many agents. MR levelsvia PPAR is dependent on phopholipase A2 activation
are upregulated by  and  interferon, (Ezekowitz et al.,and that IL-13 induces 15d-PGJ2 production and nu-
1986), 1,25-dihydroxyvitamin D3 (Clohisy et al., 1987),clear localization. These results reveal a novel signal-
prostaglandin E2 (Schreiber et al., 1993), interleukining pathway controlling the MMR surface expression
(IL)-4 and (IL)-13 (Raveh et al., 1998; Coste et al., 2002)and suggest that endogenous PPAR ligand produced
and are downregulated by interferon- (Ezekowitz et al.,
by phospholipase A2 activation may be an important
1986).
regulator of MMR expression by IL-13. Peroxisome proliferator activated receptor  (PPAR)
is a member of a family of ligand-activated nuclear tran-
Introduction scription factors which, after ligand binding, form a het-
erodimer with the retinoic X receptor. This heterodimer
The innate immune system protects the host in the early settles then to PPAR-responsive elements (PPREs) in
phase of an infection. The strategy of recognition in the promoter regions of target genes. This nuclear re-
innate response is mediated by the coordinate action ceptor has been linked initially to the regulation of adipo-
of pathogen-associated molecular patterns and pattern- genesis in adipose tissue (Tontonoz et al., 1995). Then,
recognition receptors (PRRs). The cell surface mannose it has been shown that PPAR can regulate monocyte
receptor (MR) is a key PRR of innate immunity (Stahl gene expression and differentiation (Tontonoz et al.,
and Ezekowitz, 1998). The MR receptor has been dem- 1998). This nuclear receptor is expressed in macro-
onstrated in alveolar macrophages (Stahl et al., 1978), phages where it regulates lipid homeostasis. So, PPAR
murine resident peritoneal macrophages, thioglycollate- activators induce the expression of the scavenger re-
elicited peritoneal macrophages, macrophages derived ceptor CD36 (Tontonoz et al., 1998) and conversely de-
from bone-marrow in culture (Stahl and Gordon, 1982), crease the expression of class A macrophage-scaven-
human monocyte-derived macrophages (Shepherd et ger receptor expression (Ricote et al., 1998). PPAR
may also increase the expression of the HDL receptor
CLA-1/SRB1 in vitro and in vivo in macrophages of ath-*Correspondence: pipy@toulouse.inserm.fr
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erosclerosis lesions (Chinetti et al., 2000). More recently,
it has been demonstrated that PPAR agonists increase
CD36-dependent phagocytosis of Plasmodium falci-
parum-parasitized erythrocytes and decrease parasite-
induced TNF- secretion by monocytes/macrophages
(Serghides and Kain, 2001).
PPAR is activated by a range of natural and synthetic
substances, including 15-deoxy-delta prostaglandin J2
(Forman et al., 1995), components of oxidized low-den-
sity lipoprotein, such as 13-hydroxyoctadecadienoic
acid (13-HODE) (Nagy et al., 1998) and 15-hydroxyeico-
satetraenoic acid (15-HETE), and the synthetic insulin-
sensitizing compounds, the thiazolidinediones (Leh-
mann et al., 1995). Recently, Huang et al. (1999) have
shown that IL-4-induced expression of CD36 requires
the generation of PPAR ligands via 12/15 lipoxygenases.
The effect of IL-4 exposure on expression of CD36 and
of MR on macrophage (Raveh et al., 1998) on one side
and on the production of arachidonic acid metabolites
by IL-13 (Rey et al., 1998) as IL-4 (M’Rini et al., 1997)
on the other side suggests the possibility that these
potential ligands of PPAR could be implicated in the
expression of MR in macrophages. We demonstrate
here that PPAR ligands can regulate PPAR-depen-
dent surface expression of MR and antifungal activity
of resident murine peritoneal macrophages against Can-
dida albicans. Moreover, we show that IL-13 can regu-
late MR expression via PPAR activation and 15d-PGJ2
Figure 1. PPAR-Specific Ligands and IL-13 Enhance Can-
generation via PLA2 activation. These results establish didastatic Activity of Murine Peritoneal Macrophages
that PPAR is involved in the regulation of the innate The C. albicans growth-inhibitory activity of macrophages was stud-
immune response and so contributes to the host de- ied in a 6 hr in vitro challenge with the yeast. The ratio of C. albi-
cans:macrophages was 1:200. Proliferation of the yeast was evalu-fense in the early phase of infection.
ated by following [3H]uracil incorporation into RNA of viable yeast
cells. Doses ranged between 0.01 and 6 M of 15d-PGJ2 (A), and
the effect of 1 M 15d-PGJ2 (J2), 5 M ciglitazone (cigli), 5 MResults rosiglitazone (rosi), 10 ng/ml IL-13, or of the association 15d-PGJ2
with IL-13 (B) was tested on C. albicans proliferation. Results ex-
PPAR-Specific Ligands and IL-13 Enhance pressed as the percentage of proliferation inhibition are means 
SE of three independent experiments. ** (p 0.01) indicates a signifi-Candidastatic Activity of Murine Peritoneal
cant difference compared with the control untreated macrophages.Macrophages
To study the immunopotentiating activity of PPAR ago-
nists and IL-13, macrophage monolayers were infected PPAR-Specific Ligands and IL-13 Increase
with C. albicans. Figure 1A shows that macrophages Unopsonized Candida albicans Phagocytosis
have a spontaneous fungistatic activity resulting in a and Oxidant Production by Murine
18% inhibition of Candida growth. Culture of peritoneal Peritoneal Macrophages
macrophage with 15d-PGJ2 (natural PPAR ligand) acti- Since the mechanisms of defense against Candida are
vates the candidastatic functions of the macrophages mainly dependent on the capacity of the macrophages
in a dose-dependent manner. At a concentration of 1 to phagocytize the yeasts and to exert their fungicidal
M, 15d-PGJ2 produced an inhibition of C. albicans activity by releasing large amounts of highly toxic mole-
proliferation from 60%. This concentration will be used cules such as reactive oxygen intermediates (ROIs) and
throughout our study. Figure 1B shows that 15d-PGJ2, reactive nitrogen intermediates (RNIs), we studied the
ciglitazone, and rosiglitazone (synthetic PPAR ligands) modulation of Candida phagocytosis and of oxidant
enhance the growth-inhibitory activity of macrophages agent production by macrophages after PPAR-specific
against C. albicans, causing, respectively, 70.2%, 71.5%, ligands or IL-13 treatments in the presence or absence
and 62.6% inhibition of yeast proliferation. Moreover, of GW9662, an irreversible antagonist of PPAR.
IL-13-pretreated macrophages inhibit Candida prolifer- Figure 2A shows that when the macrophages are
ation in the same manner as does 15d-PGJ2-pretreated treated by PPAR agonists, the number of [3H]uracil-
macrophages. Figure 1B shows that macrophages prelabeled C. albicans ingested increased significantly
treated with the association 15d-PGJ2/IL-13 were not by 19% for 15d-PGJ2, 13% for ciglitazone, and 10%
more active in opposing fungal growth than macro- for rosiglitazone compared to untreated macrophages
phages treated with the cytokine alone or 15d-PGJ2 which had a phagocytosis index of 46%. Moreover, we
show that IL-13 significantly increases (p  0.05) thealone.
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production of macrophages with and without overnight
15d-PGJ2 or IL-13 pretreatment. Figure 2B shows that
15d-PGJ2 or IL-13 has no effect on the basal production
of oxidizing agents by macrophages compared to un-
treated macrophages. Addition of yeast to the macro-
phage monolayer did not increase the production of
oxidizing agents by untreated macrophages but signifi-
cantly increased (p  0.01) production by the macro-
phages treated by the 15d-PGJ2 or by IL-13. So, the
yeast triggered the oxidative burst in 15d-PGJ2- or IL-
13-treated macrophages. This effect is antagonized by
GW9662 (data not shown). The effect of 15d-PGJ2 asso-
ciated with IL-13 is not higher than the effect of these
two treatments used alone. The CL production in PPAR
agonists and IL-13-pretreated macrophages was inhib-
ited significantly by SOD but not by L-NMMA, indicating
that these treatments induced principally O2. pro-
duction.
These results, which show that PPAR antagonist
blocks candidastatic effects of PPAR ligands and of
IL-13, suggest that PPAR is involved in the increase
of fungicidal activity of macrophage under the effect of
these treatments.
PPAR-Specific Ligands and IL-13 Induce Expression
of Murine Macrophage Mannose Receptors
Since the MR is involved in the phagocytosis of unopso-
nized C. albicans, the expression of MR on the surface
of PPAR-specific ligands or IL-13-treated murine peri-
toneal macrophages was examined by flow cytometry
using mannosylated bovine serum albumin labeled withFigure 2. PPAR-Specific Ligands and IL-13 Increase Unopsonized
Candida albicans Phagocytosis and Oxidizing Agent Production by fluorescein (mBSA).
Murine Peritoneal Macrophages As shown in Figures 3A and 3B, the amount of labeled
(A) The phagocytosis capacity of untreated macrophages and of 1 mBSA on murine macrophages was significantly in-
M 15d-PGJ2 (J2), 5 M ciglitazone (cigli), 5 M rosiglitazone (rosi), creased when cells were treated with 15d-PGJ2, ciglita-
or 10 ng/ml IL-13-treated macrophages in the presence or absence
zone, rosiglitazone, or with IL-13. Similarly, the sameof GW9662 (0.1 M) was studied after a C. albicans challenge of 1
increase of labeling was observed following treatmenthr. The ratio of C. albicans:macrophages was 1: 1. Values are
with the combination of 15d-PGJ2 and IL-13. The speci-means  SE of three separate experiments. ** (p  0.01) indicates
a significant difference compared with the control (untreated macro- ficity of mBSA for MMR suggests that PPAR-specific
phages). ligands and IL-13 increase protein level of MR on surface
(B) Total chemiluminescence emission (area under the curve ex- of macrophages. Figure 3C shows that the increase of
pressed in counts  seconds) was observed continuously for 60
MR surface expression by 15d-PGJ2 or IL-13 is antago-min in the presence or absence of C. albicans. Before CL measure-
nized by GW9662. This suggest the involvement ofment, the macrophages were treated with 1 M 15d-PGJ2 and/or
PPAR in upregulation of MR surface expression.10 ng/ml IL-13. NO and O2. production was also determined using
specific inhibitors (SOD, L-NMMA). When inhibitors were used, the Regression analysis of the data described in Figures
macrophages were preincubated with them 10 min before treatment. 2A and 3B shows a significant linear regression (r2	 0.942)
Data are means  SE of four separate experiments. ** (p  0.01) between MR fluorescence and phagocytosis by macro-
indicates a significant difference compared with the respective con-
phages, demonstrating a true correlation between expres-trols (15d-PGJ2 and/or IL-13-pretreated macrophages without
sion of MR as influenced by different treatments and theyeast). 2
 (p 0.01) indicates a significant difference compared with
capacity of these cells to take up C. albicans.the respective control (15d-PGJ2 and/or IL-13-pretreated macro-
phages with yeast).
PPAR-Specific Ligands and IL-13 Increase mRNA
Level of Mannose Receptor
To confirm that the increase of the mBSA binding oncapacity of macrophages to take up C. albicans (17%)
compared to untreated macrophages. The association PPAR ligands or IL-13-treated macrophages is specifi-
cally due to MMR induction and to determine whetherof IL-13 with 15d-PGJ2 has no additive or synergistic
effect. In addition, we show that the increase of the PPAR-specific ligands could function to regulate the
mRNA level of MMR, the MR mRNA-specific antisensephagocytosis index by the macrophages treated by
PPAR agonists and by IL-13 is inhibited by GW9662, was transfected into murine peritoneal macrophages.
Figure 4A shows that the treatment of macrophagesa specific PPAR antagonist.
Using chemiluminescence (CL), we next investigated with antisense resulted in a significant suppression of
the increase of mBSA binding to the macrophagesthe effect of 15d-PGJ2 or IL-13 on the oxidizing agent
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significant reduction of Ct values of MMR, indicating
a significant induction of MMR mRNA level. A linear
regression analysis shows that 15d-PGJ2 treatment was
the most effective, with an elevation of 9-fold of the
MMR mRNA level. The increase of the MMR mRNA level
by ciglitazone, rosiglitazone, and IL-13 treatments was
also important, with an elevation of 7.4-, 7.3-, and 7.6-
fold, respectively. Under the same conditions, we show
that CD36, PPAR target gene, was regulated in the
same manner by 15d-PGJ2 or by IL-13. Moreover, we
show that when the specific antisense of MMR mRNA
was transfected into macrophages the various treat-
ments abolish the increase of the MMR mRNA level but
not of CD36 mRNA.
PPAR Regulates Expression of the Macrophage
Mannose Receptor
The observation that MMR was increased following
treatment with PPAR-specific ligands raised the possi-
bility that MR might be a direct target of the PPAR.
RAW 264.7 cells express very low levels of PPARmRNA
(Ricote et al.,1998), such that activation of a PPAR-
dependent promoter required transfection of a PPAR
expression plasmid. This cell line therefore allowed a
direct assessment of the role of PPAR in mediating
the induction effects of 15d-PGJ2 and synthetic PPAR
ligands on MMR expression. Figure 5 shows in the ab-
sence of a transfected PPAR expression plasmid that
treatment of RAW 264.7 macrophages with PPAR li-
gands had no effect on MR expression. However, follow-
ing transfection with pCMX-mPPAR, PPAR ligands
increased significantly MR surface expression com-
pared to the CMV-luc control. Similar results were ob-
tained when IL-13 was used. These results show the
involvement of PPAR in upregulation of MR surface
expression.
In addition, the PPAR mRNA and MR mRNA levels
after transfection of the Raw cells with variable concen-
trations of PPAR expression plasmid were measured
by quantitative real-time RT-PCR. This study showed a
true correlation (r2 	 0.89) between PPAR mRNA andFigure 3. PPAR-Specific Ligands and/or IL-13 Induce Expression
of Murine Macrophages Mannose Receptors MR mRNA levels.
Macrophages were cultured for 24 hr in the presence of the following
activators as indicated: 1 M 15d-PGJ2, 5 M ciglitazone, 5 M
rosiglitazone, 10 ng/ml IL-13 in the presence or absence of GW9662 Mannose Receptors Are Involved in Oxidizing
(0.1 M). Cells were incubated with mBSA and analyzed by flow Agent Production of PPAR Ligandscytometry as described in the Experimental Procedures. Fluores-
or IL-13-Treated Macrophagescence distribution of the counted cell population (A) and geo mean
To evaluate the role of the MR in the oxidant agents’fluorescence intensity (B and C) are presented from a representative
experiment. Each experiment was repeated three times with similar production of the PPAR ligands or IL-13-pretreated
results. macrophages, the specific antisense of MMR mRNA
(ODN) was transfected into murine peritoneal macro-
phages. Table 1 shows that the increase of oxidizingtreated by PPAR ligands or IL-13. These results sug-
agent production by the macrophages treated by thegest that the increase of mBSA binding under the effect
15d-PGJ2 is antagonized by the specific MR mRNA anti-of PPAR-specific ligands or IL-13 results in the induc-
sense. When the PPAR ligands are used, as well as IL-tion of MR surface expression. This upregulation of MR
13, the same effect is observed. On the contrary, withsurface expression was the direct reflection of MR
nonsense/unrelated oligo (ANS) no effect on inhibitionmRNA level. To confirm that PPAR-specific ligands
of oxidizing agent production is noticed. This suggestsand IL-13 increase the MR mRNA level, the MR mRNA
that MR is specifically involved in the increase of macro-quantity was evaluated by quantitative real-time RT-
phage oxidizing agent production under the effect ofPCR. As shown in Figure 4B, the treatment with 15d-
PGJ2, ciglitazone, rosiglitazone, or IL-13 resulted in a PPAR ligands or IL-13 treatments.
IL-13 Upregulate Mannose Receptor via PPAR
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Figure 4. PPAR-Specific Ligands and/or IL-
13 Stimulate Mannose Receptor Tran-
scription
Macrophages were treated for 2 days with
medium containing MMR mRNA-specific
antisense ODN. Then, the cells were cultured
for 24 hr both in the presence of 1 M 15d-
PGJ2 (J2), 5M ciglitazone (cigli), 5M rosig-
litazone (rosi), or 10 ng/ml IL-13 and antisense
ODN as described in the Experimental Proce-
dures. Cells were incubated with mBSA, and
expression of mannose receptor was deter-
mined by flow cytometry (A). Geo mean fluo-
rescence intensity is presented from a repre-
sentative experiment. Each experiment was
repeated three times with similar results. Ef-
fect of PPAR agonists or IL-13 on MMR and
CD36 mRNA expression was also analyzed
by quantitative real-time RT-PCR (B). One
population of macrophages was treated for 2
days with medium containing antisense ODN.
Macrophages were cultured for 24 hr with 1
M 15d-PGJ2, 5M ciglitazone, 5 M rosigli-
tazone, or 10 ng/ml IL-13 in the presence of
antisense ODN. Normalization factor: (MMR
or CD36 Ct values sample/-actin Ct value
sample)  control -actin Ct value.
Cytosolic PLA2 Is Required for Macrophage Mannose nose, fucose, or N-acetylglucosamine residues on cell
surface. Mannose receptor-mediated phagocytosis mayReceptor Induction by IL-13
In order to understand the regulation of MR expression be particularly important for C. albicans because man-
nan is a main constituent of the outside layer of theby IL-13 and to reveal a physiological role of this cyto-
kine in the generation of endogenous ligands for PPAR yeast cell wall (Ezekowitz et al., 1990). MMR can be
upregulated by different molecules in particular by thevia cytosolic PLA2, we used MAFP, a specific cytosolic
PLA2 inhibitor. Figure 6A shows that MAFP does not Th2 cytokines IL-4 and IL-13 (Raveh et al., 1998) and by
prostaglandin E2 (Schreiber et al., 1993). We have shownhave any effect on induction of MR surface expression
of 15d-PGJ2-treated macrophages. On the contrary, here evidence of the involvement of the nuclear receptor
PPAR in a novel signaling pathway that upregulatesMAPF inhibits upregulation of MR expression by IL-
13. Moreover, the addition of 15d-PGJ2 restores the MR surface expression in macrophages. Ligand activa-
tion of PPAR leads to an induction of the MR expressioninduction of the MR expression in the presence of MAPF
and IL-13. To confirm that IL-13 triggers 15d-PGJ2 pro- and to the enhancement of macrophage effectrice func-
tions to fighting Candida proliferation. The study of theduction via PLA2 activation, we have studied the synthe-
sis and cellular localization of 15d-PGJ2 by immunofluo- overexpression of MMR by IL-13 also shows that PPAR
plays a role in the upregulation of MR surface expressionrescence using anti-PGJ2 polyclonal antibody. As shown
in Figure 6B, IL-13 generates 15d-PGJ2 production and by this cytokine and that this process is cytosolic PLA2
dependent.induces 15d-PGJ2 nuclear localization in macrophages.
These findings suggest that IL-13 can positively regu- Exposure of monocytes and macrophages to IL-13
activates several functions associated with enhancedlate gene expression in macrophages partly by control-
ling the production of endogenous ligands of PPAR cellular immunity. It suppresses the production of IL-1,
IL-12, and IL-8 and stimulates the production of IL-1such as 15d-PGJ2. This work reveals a physiological
role of cytosolic PLA2 in the generation of endogenous receptor antagonist, thereby playing an essential anti-
inflammatory role (Minty et al., 1997). IL-13 induces anligands for PPAR.
alternative activated state in macrophages, notably by
regulating the phagocytosis process partially via theDiscussion
upregulation of MR (Montaner et al., 1999; Coste et al.,
2002) and the downregulation of CD14. While the mech-The macrophage mannose receptor is believed to func-
tion in innate immunity by recognizing and phagocyting anism that transduces signals from IL-13 to the MR
gene are not defined, previous studies have shown thatunopsonized microorganisms bearing terminal man-
Immunity
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SP1 and the lymphoid/myeloid factor PU.1 (Eichbaum
et al., 1997). In this study, we show that the endogeneous
PPAR ligand 15d-PGJ2, the synthetic PPAR agonists
thiazolidinedione compounds, and IL-13 upregulate
MMR expression. This enhancement of MR surface ex-
pression is dependent on an increase of the MMR mRNA
level since the specific antisense of MMR mRNA abol-
ishes this induction whereas contrarily the nonspecific
antisense does not have any effect. Our results also
suggest that IL-13 and the PPAR agonists upregulated
MMR via PPAR. Indeed, in the absence of PPAR in
murine macrophage cell line RAW 264.7, IL-13 or PPAR
agonists do not induce the increase of MR expression.
Moreover, the effect of the PPAR agonists or of IL-
13 on this expression is restored by the pCMX-PPAR
transfection in these cells. In addition, these data are
strengthened by the inhibition of the upregulation of
MR surface expression by the GW9662, an irreversible
antagonist of PPAR. So, our results show that PPAR is
implicated in the MR surface overexpression by PPAR
agonists and by IL-13. The hypothesis of a transcrip-
tional regulation of MMR by PPAR activation is strongly
suggested by in silico analysis of MR promoter using
genomatix software. Two putative PPAR response ele-
ments (PPRE) were found between 528 and 508 and
between 418 and 394 of the transcription start site
in the reverse strand of this promoter.
PPAR is a member of the nuclear hormone receptor
superfamily that functions as a transcriptional regulator
of genes, in particular in macrophages. So, the type BFigure 5. PPAR Regulates Expression of Macrophage Mannose
scavenger receptor CD36 is induced by PPAR (HuangReceptors
et al., 1999; Nagy et al., 1998; Tontonoz et al., 1998).The macrophage murine cell line RAW 267.4 was transiently trans-
The consequence of this overexpression is an enhance-fected for 18 hr with pCMX-mPPAR (PPAR expression plasmid)
or CMV-luc (control). RAW 267.4 were cultured for 24 hr in the ment of the ability to phagocytize Plasmodium falci-
presence of 1 M 15d-PGJ2, 5 M ciglitazone, 5 M rosiglitazone, parum-parasitized erythrocytes and a decrease of ma-
or 10 ng/ml IL-13. Cells were incubated with mBSA and analyzed laria-induced TNF- secretion (Serghides and Kain,
by flow cytometry as described in the Experimental Procedures. 2001). Phagocytosis plays an important role in the micro-
Fluorescence distribution of the counted cell population (A) and geo
bicidal function of the macrophages against C. albicans.mean fluorescence intensity (B) are presented from a representative
Several studies showed that MR is sufficient to mediateexperiment. Each experiment was repeated three times with similar
phagocytosis of unopsonized Candida albicans. Duringresults.
our work the role of this receptor in this process is
suggested by the experiment which shows that C. albi-
prostaglandins (Schreiber et al., 1993) upregulate MR cans phagocytosis was inhibited by MR agonists (man-
expression. Currently, only some studies show that nosylated albumin).We demonstrate here that the treat-
mannose receptor gene expression is regulated by the ment of macrophages with IL-13 or with PPAR-specific
ligands enhances the capacity of these cells to ingestinteraction between the ubiquitously expressed factor
Table 1. Mannose Receptors Are Involved in Oxidizing Agents Production of PPAR Ligands or IL-13-Treated Macrophages
Oxidizing agents production (counts  seconds)
Treatment Without Antisense With ODN With ANS
Control 6737  139 6795  178 6972  90
15d-PGJ2 9161  85

 7012  98** 9678  106


Ciglitazone 8398  104

 7109  155** 8322  183


Rosiglitazone 8960  179

 7197  77** 8813  190


IL-13 8653  92

 7095  104** 8513  47


Total chemiluminescence emission (area under the curve expressed in counts  seconds) was observed continuously for 60 min during C.
albicans challenge. Before CL measurement, the macrophages were incubated for 2 days with a specific antisense (ODN) or a nonsense oligo
nonspecific antisense (ANS) of mannose receptor mRNA. The macrophages were cultured for 24 hr with 1 M 15d-PGJ2, 5 M ciglitazone,
5 M rosiglitazone, or 10 ng/ml IL-13 in the presence of antisense ODN as described in the Experimental Procedures. Data are means  SE
of four separate experiments. 

 (p  0.01) indicates a significant difference compared with the control without antisense or with ANS
antisense. **(p  0.01) indicates a significant difference compared with the respective controls (15d-PGJ2, ciglitazone, rosiglitazone, or IL-13
pretreated macrophages without antisense).
IL-13 Upregulate Mannose Receptor via PPAR
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phages triggered by Candida albicans. We show that
pretreatment of mouse resident peritoneal macro-
phages with IL-13 or with PPAR-specific ligands en-
hance oxidizing agents released in response to chal-
lenge by C. albicans. SOD, a specific inhibitor of
superoxide anion production, one of the products of ROI
metabolism that is essential for macrophage oxidative
killing, inhibits oxidizing agent production induced by
Candida albicans in macrophages pretreated by PPAR-
specific ligands or IL-13. Contrarily, L-NMMA, a specific
competitor of L-arginine inhibiting nitric oxide (NO) pro-
duction, does not inhibit this ROI production. These
results indicated that PPAR-specific ligands or IL-13
induced principally superoxide production by macro-
phages confronted with fungal challenge. The absence
of the production of NO by the macrophages treated by
IL-13 or PPAR ligands is confirmed by direct measure-
ment by the Griess method of the nitrite production
by the macrophages under the effect of the various
treatments (data not shown). Previous studies show that
IL-13 was found to be a potent suppressor of NO pro-
duction in activated macrophages (Bogdan et al., 1997).
Also, the induction of nitric oxide synthetase was re-
pressed by PPAR ligands (Ricote et al., 1998). On the
contrary, in our laboratory, previous studies have shown
that IL-13 inhibits slightly the oxidative hyperactivity of
the human monocyte triggered by 12-O-tetradeca-
noylphorbol-13-acetate (TPA) via a mechanism which
involves the activation of the MAP kinases and protein
kinase A (Sozzani et al., 1995). The divergence between
these two results suggest that IL-13 could modulate
differently the respiratory burst when administered si-
multaneously with inflammatory agonists or prior to the
macrophage stimulation. Indeed, during the previous
study the duration of the exposition of human monocyte-
derived macrophages with IL-13 was brief, and the re-
Figure 6. Implication of cPLA2 in Macrophage Mannose Receptor
spiratory burst was triggered by activation of PKC withInduction and in 15d-PGJ2 Production by IL-13
TPA. In this study the exposure of macrophages withMacrophages were treated for 10 min with MAFP (10 M) as de-
IL-13 is long (24 hr), and we prove that the increase of thescribed in the Experimental Procedures. The cells were cultured for
ROIs production was correlated with the upregulation of24 hr in the presence of the following activators: 1 M 15d-PGJ2,
MR surface expression. Indeed, the increase of ROIs5 M ciglitazone, 5 M rosiglitazone, 10 ng/ml IL-13. Cells were
incubated with labeled mBSA, and expression of mannose receptor production by the macrophages treated by PPAR ago-
was determined by flow cytometry. Mean fluorescence intensity is nists or by IL-13 was antagonized by the specific anti-
presented from a representative experiment. Each experiment was sense of MR mRNA. The involvement of MR in the oxidiz-
repeated three times with similar results (A). The visualization of
ing agent production by macrophages challenged by15d-PGJ2 production and nuclear translocation under the effect of
Candida albicans was supported by several works whichIL-13 was also analyzed by confocal laser microscopy. Macro-
show that when the MR was engaged by microorgan-phages were treated for 20 min with IL-13 (10 ng/ml) as indicated.
isms or particles, a signal-transducing pathway triggersThe fixed cells were treated with anti-15d-PGJ2 mouse polyclonal
antibody, followed by fluorescein isothiocyanate-conjugated anti- a variety of responses including secretion of reactive
mouse Ig. Nuclear staining was performed by propidium iodide. The oxygen intermediates (Berton and Gordon, 1983). Prein-
red color represents the nucleus (left panels); green color represents cubation of murine peritoneal macrophage with soluble
15d-PGJ2 (middle panels). Merged pictures of green and red colors
MR ligands enhanced killing of phagocytosed opso-are shown in the right panels (B).
nized E. coli via generation of reactive oxygen intermedi-
ates (Lefkowitz et al., 1997). Thus, here the superoxide
unopsonized C. albicans via the upregulation of MR sur- anion-mediated killing of Candida albicans in macro-
face expression. The use of GW9662 proves that PPAR phages treated by PPAR agonists or by IL-13 plays
is really involved in the increase of macrophage ability a complementary role to phagocytosis capacity in the
to phagocytose C. albicans. control of the yeast proliferation by the macrophages.
We show that the enhancement of the fungicidal activ- The use of GW9662 provides the strongest evidence for
ity by PPAR ligands or by IL-13 was higher than the a role of PPAR in the enhancement of macrophage
enhancement of the phagocytosis. As respiratory burst candidastatic activity by PPAR agonists or by IL-13.
is of critical importance in host defense in candidacidal For several years, our laboratory has studied the
activity of macrophages (Vazquez-Torres and Balish, mechanisms regulating the effector functions of the
macrophages and monocytes by Th2 cytokines, and we1997), we have studied the production of ROIs by macro-
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tient. The isolate was identified as Candida albicans based on com-have implicated the arachidonic acid pathway in the
mon laboratory criteria and cultured on Sabouraud dextrose agarmodulation of the inflammatory processes by IL-13.
plates containing gentamicin and chloramphenicol.Thus, the exposure of the mouse peritoneal macro-
phages to IL-13 activates the acid arachidonic metabo-
Cell Culture
lism via the increase of cPLA2 expression (Rey et al., Murine resident peritoneal cells were harvested from female Swiss
1998) and cPLA2 activation by serine phosphorylation mice. In brief, cells were obtained by injection into the peritoneal
(Rey et al., 1999). In addition, IL-4, a Th2 cytokine which cavity of sterile 199 medium with Hank’s salts. Collected cells were
centrifuged, and the cell pellet was suspended in serum-free me-shares in its receptor at least one common chain called
dium (SFM) optimized for macrophage culture (Gibco InvitrogenIL-4R, with IL-13 enhances the macrophage arachi-
Corporation, France). Cell adhesion was allowed during 2 hr at 37Cdonic acid metabolism (M’Rini et al., 1997), and IL-13
with 5% CO2 atmosphere in 24- or 96-well culture plates. Nonadher-as well as IL-4 produces an overexpression of 5-lipoxy- ent cells were removed by washing with phosphate-buffered saline
genase (Escoubet-Lozach et al., 2001). Interestingly, the (PBS) (Gibco Invitrogen Corporation), and the remaining adherent
group of C. Glass has recently reported that IL-4 may cells were stimulated by different concentration of 15d-PGJ2, cigli-
tazone, rosiglitazone (Cayman Chemical, USA), or IL-13 (Sanofi Syn-generate natural PPAR ligands by enzymatic oxidation
thelabo, France) diluted in SFM as described in the figures. In someof polyunsaturated fatty acids. Indeed, Huang et al.
experiments, macrophages were incubated with specific inhibitor(1999) have provided evidence that the 12/15 lipoxygen-
of cPLA2, MAFP (10 M), 10 min before the addition of PPARases, which had previously been implicated in the cellu-
ligands or IL-13.
lar oxidation of LDL, may serve to generate oxidized fatty After 2 hr of adhesion, 98% of adherent cells were nonspecific
acid ligands of PPAR and are required for a maximal esterase positive and had the morphological appearance of macro-
phages by May-Grunwald Giemsa staining.induction of the CD36 gene by IL-4. Macrophages ex-
pressing these enzymes catalyze the conversion of lino-
Candida Proliferation Assayleic acid and arachidonic acid into the PPAR activators
C. albicans growth in monolayer cultures was measured by monitor-13-hydroxyoctadecadienoic acid (13-HODE) and 15-
ing [3H]uracil (Amersham Pharmacia Biotech, France) incorporationhydroxyeicosatetraenoic acid (15-HETE), respectively.
(1 Ci/well) into RNA of viable yeast cells in multiplication process.
Despite the fatty acids result of the modified LDL, it is [3H]uracil incorporation into C. albicans can be used as a sensitive
not excluded that the arachidonic acid can be mobilized index of proliferation. For each assay, 2  105 macrophages per
from membrane phospholipids after activation of a cyto- well were cultivated for 2 hr in 96-well Falcon plates in SFM at 37C
and 5% CO2, stimulated by the PPAR agonists or IL-13 for 24 hr,solic PLA2 by IL-4 and would be subsequently metabo-
and used for infection as follows. Macrophage monolayers werelized by the cyclooxygenase or lipoxygenase pathways.
infected with blastoconidies to give a Candida:macrophage ratio ofSince IL-13 activates cPLA2 in murine peritoneal macro-
1:200 for 6 hr at 37C. Labeled uracil (1 Ci) was added to eachphages (Rey et al., 1999) and phospholipase A2 activa-
well. After challenging macrophages with blastospores (6 hr), the
tion is required to produce endogenous PPAR ligands radioactivity incorporated into yeast RNA of nonadherent blas-
via lipoxygenase or cyclooxygenase pathways, we have tospores and of adherent or phagocyted yeasts was counted with
used a cPLA2 inhibitor to determine the implication of BCS scintillation fluid (Amersham) as described previously (Coste
et al., 2002).this enzyme in the upregulation of MR surface expres-
sion. cPLA2 inhibition blocks the MR surface induction
Phagocytosis Assayby IL-13, and this MMR overexpression is restored by
To investigate the mechanism of C. albicans ingestion by murinethe addition of 15d-PGJ2. In addition, the implication of
peritoneal macrophages, we used [3H]uracil-prelabeled yeasts.15d-PGJ2 in MR overexpression by IL-13 is also sug-
Three C. albicans colonies were dispersed in 1 ml of Sabouraud
gested by confocal microscopy study which shows that broth containing 150 Ci [3H]uracil. After 24 hr of growth at 37C,
IL-13 generates 15d-PGJ2 production and 15d-PGJ2 the pellet was resuspended in SFM supplemented with glucose
nuclear localization in macrophages. Thus, we demon- 1.8%. For each assay, macrophage monolayers in 24-well Falcon
plates were treated with PPAR agonists or IL-13 for 24 hr in thestrate that IL-13 can positively regulate MMR surface
absence or presence of an irreversible antagonist of PPAR,expression partly by controlling the production of
GW9662 (Huang et al., 1999). Then the macrophages were infectedPPAR endogenous ligands, particularly 15d-PGJ2, via
with viable labeled C. albicans for 1 and 2 hr (ratio of macro-cPLA2 activation. This regulation of MMR which is also
phage:yeast, 1:1) at 37C and at 5C, respectively, to study the
obtained with synthetic PPAR ligands, is PPAR de- Candida internalization by the macrophages and the Candida-cell
pendent. adhesion. After each incubation period (1 or 2 hr), the culture medium
These observations show that PPAR and the ligands was collected, the monolayers washed twice with PBS, and the
washings kept. The monolayers were disrupted as described pre-of this nuclear receptor are involved in the regulation of
viously. The radioactivity of the supernatant and washings and theinnate immune response against opportunistic patho-
radioactivity contained in the cellular lysate were counted indepen-gens which, as Candida albicans, are eliminated by the
dently. The index of phagocytosis is calculated with the followingMR. These results suggest the possibility that PPAR
equation:
ligands may be of therapeutic value in human diseases
% phagocytosis 	 (37C-5C) dpm monolayers/such as candidiasis in immunocompromised patients
because they increase the innate immune response ((37C-5C) dpm monolayers 
 dpm supernatant). (1)
by enhancing the expression of MR implicated in the
direct recognition, internalization, and killing of these
Flow Cytometrypathogens.
To evaluate MMR surface expression, we have used MMR-specific
ligand conjugated with FITC. Macrophage monolayers were washedExperimental Procedures
with ice-cold PBS and scraped. The cells were recovered and incu-
bated with a mannosylated bovine serum albumin labeled with FITCCandida albicans Strains
(mBSA) (840 nM) (Raveh et al., 1998; Yamamoto et al., 1997). TheThe strain of C. albicans used throughout these experiments was
isolated from a blood culture of a Toulouse-Rangueil Hospital pa- labeling of the MMR was done during 1 hr on ice. In our study we
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checked that the binding of the FITC-Mannose-BSA could be fully changes of medium containing antisense ODN. Then, the cells were
incubated during 24 hr with PPAR-specific agonists or IL-13 in thereversed by mannose BSA without FITC or yeast mannan addition
but not by BSA. presence of ODN antisense. For this period of treatment the MR
basal expression remains stable. The concentration of antisenseIn order to facilitate the selection of viable cell population, a stain-
ing with propidium iodide was done. All analyses were done on a ODN used showed no significant toxicity to macrophages as deter-
mined by the tetrazolium dye reduction assay with 3-(4,5-dimethyl-Becton Dickinson FACScan using CellQuest software. A population
of 20,000 viable cells was analyzed for each data point. thiazol-2-yl)-2,5-diphenyltetrazolium bromide. Macrophages treated
with only lipofectin and with nonsense/unrelated oligo 5-GGT
TCCTTTCCTGATTTACG-3 (ANS) served as control.Analysis of Mannose Receptor, CD36 and PPAR cDNA Using
a Quantitative Real-Time RT-PCR
Assay for Oxidizing Agent ProductionTotal RNA was isolated from cell populations using Extract All Re-
The oxygen-dependent respiratory burst of murine macrophagesagent (Eurobio, France) and reverse transcribed using the First-
treated or not by specific or nonspecific antisense of mannose re-Strand cDNA Synthesis Kit (Promega, France). PCR for MR, CD36,
ceptor mRNA, as previously described, was measured by chemilu-PPAR, and -actin cDNA was performed with the LC FastStart
minescence in the presence of 5-amino-2,3-dihydro-1,4-phthalaz-DNA master SYBR Green I (Roche) in a standard PCR reaction.
inedione (luminol) using a thermostatically (37C) controlledAmplification and detection were performed in a LightCycler instru-
luminometer (Wallac 1420 Victor2, Finland). The generation of CLment as follows. Twenty microliters of reaction mixture was incu-
was monitored continuously for 1 hr after incubation of the cellsbated initially for 10 min at 95C to activate the Fast Start Taq DNA;
with luminol (66 M) and after C. albicans challenge. Before CLamplifications were performed for 35 cycles (5 s at 95C, 10 s at
measurement, cells were incubated with PPAR agonists or IL-1350C, and 40 s at 68C) for MMR, for 34 cycles (5 s at 95C, 10 s
during 24 hr. To assess superoxide anion (O2.) production, CL wasat 56C, and 40 s at 72C) for CD36, for 40 cycles (5 s at 95C, 10 s
measured in the presence of SOD (scavenger for O2.), and to evalu-at 63C, and 20 s at 72C) for PPAR, and for 30 cycles (5 s at 95C,
ate NO production, CL was measured in the presence of L-NMMA10 s at 56C, and 20 s at 72C) for -actin. Results of the real-time
(a specific competitor of L-arginine for NO production). None of thePCR data were represented as Ct values, where Ct was defined as
inhibitors affected cell viability at the concentrations used. Statisti-the threshold cycle of PCR at which amplified product was first
cal analysis was performed using the area under the curve ex-detected. The primers used for real-time quantitative PCR were
pressed in counts  seconds.5-GCTCTAGAATGGAACACACACTCTGGGCCATG-3 (sense) and
5-GCTCTAGAATGGAACACACTCTGGGCCATG-3 (antisense) for
Confocal MicroscopyMMR; 5-AGGTCCTTACACATACAGAGTTCG-3 (sense) and 5-GGA
Macrophages were cultured on a Lab-Tek chamber slide and wereCTTGCATGTAGGAAATGTGGA-3 (antisense) for CD36; 5-GATGCA
stimulated by IL-13 for 20 min. The cells were then fixed with 4%AGGGTTTCTTCCGGAGAAC-3 (sense) and 5-TGGTGATTTGTC
paraformaldehyde in PBS for 10 min, permeabilized in PBS con-TGTTGTCTTTCC-3 (antisense) for PPAR; 5-GTGGGGCGCCCC
taining 0.1% Triton X-100 for 30 min, and rinsed in PBS. The fixedAGGCACA-3 (sense) and 5-CTCCTTAATGTCACGCACGATTTC-3
cells were incubated with anti-15d-PGJ2 mouse polyclonal antibody(antisense) for -actin.
(1:50) (Shibata et al., 2001) for 16 hr at 4C and then with fluoresceinTo examine the sensitivity and linearity of the assay, a serial dilu-
isothiocyanate-conjugated anti-mouse Ig for 1 hr. Nuclei weretion of the positive control sample was used. The linearity of RNA
stained with propidium iodide at 10 g/ml. A confocal laser-scan-concentrations versus Ct values of the PCR reaction in the serially
ning microscope (LSM 510, Zeiss) was used to visualize the produc-diluted samples was calculated by linear regression analysis (Y 	
tion and localization of 15d-PGJ2.4.229X  2.660). The Ct values change proportionally according to
the serial dilution of the sample. The correlation coefficient of the
Statistical AnalysisRNA concentration and Ct value (r2	 0.983) indicate that the quantity
The data are expressed as meanSE of three separate experimentsof RNA is adequately represented by the Ct value.
with three replications per experiment. For each experiment, the
data were subjected to one-way analysis of variance followed byTransfection Assays
the means multiple comparison method of Tukey. p  0.05 wasThe macrophage murine cell line RAW 267.4 was maintained in an
considered as the level of statistical significance.exponential growth phase by subsequent splitting in DMEM comple-
mented with 10% of FBS. The day prior to transfection, cells were
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